Related Experiment Video
Updated: Jun 29, 2025

Magnetic Resonance Imaging Quantification of Pulmonary Perfusion using Calibrated Arterial Spin Labeling
Published on: May 30, 2011
Arterial spin labeled perfusion MRI for the assessment of radiation-treated meningiomas
Paul Manning1,2, Shanmukha Srinivas2, Divya S Bolar1,3
1Department of Radiology, University of California, San Diego, San Diego, CA, United States.
Purpose:
Conventional contrast-enhanced MRI is currently the primary imaging technique used to evaluate radiation treatment response in meningiomas. However, newer perfusion-weighted MRI techniques, such as 3D pseudocontinuous arterial spin labeling (3D pCASL) MRI, capture physiologic information beyond the structural information provided by conventional MRI and may provide additional complementary treatment response information. The purpose of this study is to assess 3D pCASL for the evaluation of radiation-treated meningiomas.
Methods:
Twenty patients with meningioma treated with surgical resection followed by radiation, or by radiation alone, were included in this retrospective single-institution study. Patients were evaluated with 3D pCASL and conventional contrast-enhanced MRI before and after radiation (median follow up 6.5 months). Maximum pre- and post-radiation ASL normalized cerebral blood flow (ASL-nCBF) was measured within each meningioma and radiation-treated meningioma (or residual resected and radiated meningioma), and the contrast-enhancing area was measured for each meningioma. Wilcoxon signed-rank tests were used to compare pre- and post-radiation ASL-nCBF and pre- and post-radiation area.
Results:
All treated meningiomas demonstrated decreased ASL-nCBF following radiation (p < 0.001). Meningioma contrast-enhancing area also decreased after radiation (p = 0.008) but only for approximately half of the meningiomas (9), while half (10) remained stable. A larger effect size (Wilcoxon signed-rank effect size) was seen for ASL-nCBF measurements (r = 0.877) compared to contrast-enhanced area measurements (r = 0.597).
Conclusions:
ASL perfusion may provide complementary treatment response information in radiation-treated meningiomas. This complementary information could aid clinical decision-making and provide an additional endpoint for clinical trials.
Insights
3D pseudocontinuous arterial spin labeling (3D pCASL) MRI shows decreased cerebral blood flow in radiation-treated meningiomas, offering complementary insights beyond conventional MRI. This perfusion imaging may aid clinical decisions and serve as a trial endpoint.
Area of Science:
- Neuroimaging
- Radiology
- Oncology
Background:
- Conventional contrast-enhanced MRI is the standard for evaluating radiation treatment response in meningiomas.
- Perfusion-weighted MRI techniques, like 3D pseudocontinuous arterial spin labeling (3D pCASL), offer physiological data beyond structural information.
- 3D pCASL may provide complementary information for assessing treatment response in meningiomas.
Purpose of the Study:
- To assess the utility of 3D pCASL MRI in evaluating radiation-treated meningiomas.
- To compare the effectiveness of 3D pCASL with conventional contrast-enhanced MRI for treatment response assessment.
Main Methods:
- Retrospective study of 20 patients with meningiomas treated with surgery and/or radiation.
- Patients underwent 3D pCASL and contrast-enhanced MRI before and after radiation therapy.
- Measurements included ASL-normalized cerebral blood flow (ASL-nCBF) and contrast-enhancing area; Wilcoxon signed-rank tests were used for comparison.
Main Results:
- All treated meningiomas showed a significant decrease in ASL-nCBF post-radiation (p < 0.001).
- Contrast-enhancing area decreased in only half of the meningiomas, remaining stable in the other half.
- ASL-nCBF measurements demonstrated a larger effect size (r=0.877) compared to contrast-enhanced area measurements (r=0.597).
Conclusions:
- 3D pCASL perfusion imaging provides complementary information for evaluating radiation response in meningiomas.
- This technique may enhance clinical decision-making for meningioma patients.
- 3D pCASL could serve as an additional endpoint in clinical trials for radiation-treated meningiomas.
More Related Videos
05:23Author Spotlight: Noninvasive Cerebral Blood Flow Determination in Human Functional Brain Region for Diagnosis of Neurological Disorders
Published on: May 31, 2024
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022